- Home
- BDN vs ANAB Comparison
BDN vs ANAB Comparison
Compare BDN & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDN
- ANAB
- Stock Information
- Founded
- BDN 1986
- ANAB 2005
- Country
- BDN United States
- ANAB United States
- Employees
- BDN N/A
- ANAB N/A
- Industry
- BDN Real Estate Investment Trusts
- ANAB Biotechnology: Pharmaceutical Preparations
- Sector
- BDN Real Estate
- ANAB Health Care
- Exchange
- BDN Nasdaq
- ANAB Nasdaq
- Market Cap
- BDN 693.1M
- ANAB 630.2M
- IPO Year
- BDN N/A
- ANAB 2017
- Fundamental
- Price
- BDN $4.60
- ANAB $20.16
- Analyst Decision
- BDN Hold
- ANAB Buy
- Analyst Count
- BDN 1
- ANAB 10
- Target Price
- BDN $5.00
- ANAB $48.00
- AVG Volume (30 Days)
- BDN 2.0M
- ANAB 427.6K
- Earning Date
- BDN 10-21-2025
- ANAB 11-04-2025
- Dividend Yield
- BDN 13.04%
- ANAB N/A
- EPS Growth
- BDN N/A
- ANAB N/A
- EPS
- BDN N/A
- ANAB N/A
- Revenue
- BDN $306,596,000.00
- ANAB $123,164,000.00
- Revenue This Year
- BDN $55.21
- ANAB $11.40
- Revenue Next Year
- BDN $3.34
- ANAB $8.17
- P/E Ratio
- BDN N/A
- ANAB N/A
- Revenue Growth
- BDN N/A
- ANAB 304.17
- 52 Week Low
- BDN $3.41
- ANAB $12.21
- 52 Week High
- BDN $6.54
- ANAB $40.55
- Technical
- Relative Strength Index (RSI)
- BDN 69.47
- ANAB 41.04
- Support Level
- BDN $4.26
- ANAB $20.61
- Resistance Level
- BDN $4.46
- ANAB $23.64
- Average True Range (ATR)
- BDN 0.11
- ANAB 1.22
- MACD
- BDN 0.04
- ANAB 0.23
- Stochastic Oscillator
- BDN 99.00
- ANAB 10.92
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).